NewAmsterdam Pharma Presents Additional Data From Pivotal Phase 3 Brooklyn Clinical Trial Evaluating Obicetrapib in Patients With Heterozygous Familial Hypercholesterolemia at Aha Scientific Sessions 2024
NewAmsterdam製藥在2024年Aha科學會議上發佈了關於在雜合子家族性高膽固醇血癥患者中評估Obicetrapib的關鍵3期布魯克林臨床試驗的額外數據
